A Schema for Effective Osteoporosis Management: Outcomes of the Geisinger Health System Osteoporosis Program

Disease Management and Health Outcomes

Volumn 11, Issue 10, 2003, Pages 611-616

  Newman, Eric D ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VITAMIN D;

BONE DENSITY; COST EFFECTIVENESS ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FRACTURE REDUCTION; HEALTH CARE SYSTEM; HEALTH PROGRAM; HIP FRACTURE; HUMAN; LIFESTYLE; OSTEOPOROSIS; OUTCOMES RESEARCH; PATIENT CARE; PATIENT EDUCATION; PRESCRIPTION; REVIEW; WEIGHT BEARING;

EID: 0142217294     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200311100-00001     Document Type: Review

References (35)

1. Discher CL, Klein D, Pierce L, et al. Heart failure disease management: impact on hospital care, length of stay, and reimbursement. Congest Heart Fail 2003; 9: 77-83
2. Rothman R, Malone R, Bryant B, et al. Pharmacist-led, primary care-based disease management improves hemoglobin A 1c in high-risk patients with diabetes. Am J Med Qual 2003; 18: 51-8
3. Georgiou A, Buchner DA, Ershoff DH, et al. The impact of a large-scale population-based asthma management program on pediatric asthma patients and their caregivers. Ann Allergy Asthma Immunol 2003; 90: 308-15
4. Ross PD. Osteoporosis: frequency, consequences, and risk factors. Arch Intern Med 1996; 156: 1399-411
5. Lindsay R, Meunier PJ. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost effectiveness analysis: the basis for a guideline for the medical management of osteoporosis. Osteoporos Int 1998; 8 Suppl. 4: 1-88
6. Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12: 24-35
7. Newman ED, Ayoub WT, Starkey RH, et al. Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporos Int 2003; 14: 146-51
8. Newman ED, Hanus P. Improved bone health behavior using community pharmacists as educators: the Geisinger Health System Community Pharmacist Osteoporosis Education Program. Dis Manage Health Outcomes 2001; 9: 329-35
9. Kanis JA, Delmas P, Burckhardt P, et al. Guidelines for the diagnosis and management of osteoporosis. Osteoporos Int 1997; 7: 390-406
10. Scheiber LB, Torregrosa L. Evaluation and treatment of postmenopausal osteoporosis. Semin Arthritis Rheum 1998; 27: 245-61
11. Meunier PJ, Delmas PD, Eastell R, et al. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. Clin Ther 1999; 21: 1025-44
12. Compston J. Prevention and treatment of osteoporosis: clinical guidelines and new evidence. J R Coll Physicians Lond 2000; 34: 518-21
13. Sambrook P, O'Neill S, Diamond T, et al. Postmenopausal osteoporosis treatment guidelines. Aust Fam Physician 2000; 29: 751-8
14. Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 2001; 7: 294-312
15. Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002: 167 (10 Suppl.); S1-34
16. Sledar SJ, Hess M. Implementation of a drug-use and disease-state management program. Am J Health Syst Pharm 2000; 57 Suppl. 4: S23-9
17. Taft LB, Looker PA, Cella D. Osteoporosis: a disease management opportunity. Orthop Nurs 2000; 19: 67-76
18. Kanis JA, Gluer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 2000; 11: 192-202
19. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 359: 1929-36
20. Dawson-Hughes B, Dallal GE, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990; 323: 878-83
21. Dawson-Hughes B, Dallal GE, Krall EA, et al. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991; 115: 505-12
22. Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. J Clin Endocrinol Metab 2000; 85: 4118-24
23. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001; 344: 333-40
24. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999; 282: 637-45
25. Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int 2003; 14 Suppl. 3: S13-8
26. Chestnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study. Am J Med 2000; 109: 267-76
27. Hauselmann HJ, Rizzoli R. A comprehensive review of treatments for postmenopausal osteoporosis. Osteoporos Int 2003; 14: 2-12
28. Lydick E, Cook K, Turpin J, et al. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care 1998; 4: 37-48
29. Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001; 12: 519-28
30. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results form the National Osteoporosis Risk Assessment. JAMA 2001; 286: 2815-22
31. Miller PD, Njeh CF, Jankowski LG, et al. What are the standards by which bone mass measurement at peripheral skeletal sites should be used in the diagnosis of osteoporosis? J Clin Densitom 2002; 5 Suppl.: S39-45
32. Binkley NC, Schmeer P, Wasnich RD, et al. What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J Clin Densitom 2002; 5 Suppl.: S19-27
33. Kanis JA, Johnell O, Oden A, et al. Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 2002; 30: 251-8
34. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001; 12: 989-95
35. Berwick D. Developing and testing changes in delivery of care. Ann Intern Med 1998; 128: 651-6